Wegovys dosing schedule gradually increases over time to reduce side effects
This is fundamentally different from, say, a small molecule drug where stability is routinely tested per USP monograph
Furthermore, the study found no increased risk of hospitalization for side effects like diabetic ketoacidosis or severe hypoglycemia, suggesting that GLP-1RAs may represent a promising adjunctive therapy warranting further study in T1D management
For users new to self-injection, these instructions serve as the primary educational resource for technique, since there is no provider call or pharmacist consultation built into the standard Brello process
In Part 1, we talked about the history of triple receptor hormone agonists targeting GLP-1, GIP, and glucagon